Literature DB >> 16326141

Myoclonic encephalopathy in the CDKL5 gene mutation.

Sabrina Buoni1, Raffaella Zannolli, Vito Colamaria, Francesca Macucci, Rosanna M di Bartolo, Letizia Corbini, Alessandra Orsi, Michele Zappella, Joseph Hayek.   

Abstract

OBJECTIVE: Epilepsy with mutation of the CDKL5 gene causes early seizures and is a variant of Rett syndrome (MIM (312750), which is reported typically as infantile spasms. The purpose of this study was to analyze the epileptic histories and EEGs of patients with the CDKL5 mutation.
METHODS: We reviewed the epilepsy histories and electroclinical analyses of three girls aged 9.5, 7.4, and 9.4 years, each with a mutation of the CDKL5 gene.
RESULTS: We revealed the presence of an encephalopathy that started by 1.5 months of age. At first, seizures involved tonic spasms or complex partial seizures, and were complicated by the later appearance of complex partial, tonic, and unexpectedly, myoclonic seizures. This form of epilepsy was drug resistant. Routine and prolonged video EEGs both displayed a homogeneous electroclinical pattern consisting of (a) unique background with diffuse high voltage sharp waves of 6-7 Hz, and absence of the typical rhythmic frontal-central theta activity present in Rett syndrome; (b) unique awake and sleep background, with diffuse, high voltage, continuous sharp waves with multifocal and diffuse spikes; (c) rhythmic, diffuse, 15 Hz activity accompanied clinically by tonic seizures; (d) intercritical pattern with pseudoperiodic, diffuse, sharp waves or pseudoperiodic, diffuse spike and polyspike or wave discharges; and (e) diffuse, spike, polyspike and wave discharges accompanied by massive or focal myoclonias or both.
CONCLUSIONS: Patients with the CDKL5 mutation have an early onset, epileptic encephalopathy in infancy that evolves into myoclonic seizures in childhood with a unique EEG pattern. SIGNIFICANCE: Recognizing this type of encephalopathy could be useful in prompting clinicians to proceed further with their diagnostic work in patients not fitting the criteria of classical Rett syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326141     DOI: 10.1016/j.clinph.2005.09.008

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  10 in total

Review 1.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

Review 2.  Severity Assessment in CDKL5 Deficiency Disorder.

Authors:  Scott Demarest; Elia M Pestana-Knight; Heather E Olson; Jenny Downs; Eric D Marsh; Walter E Kaufmann; Carol-Anne Partridge; Helen Leonard; Femida Gwadry-Sridhar; Katheryn Elibri Frame; J Helen Cross; Richard F M Chin; Sumit Parikh; Axel Panzer; Judith Weisenberg; Karen Utley; Amanda Jaksha; Sam Amin; Omar Khwaja; Orrin Devinsky; Jeffery L Neul; Alan K Percy; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-03-27       Impact factor: 3.372

3.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

4.  CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients.

Authors:  H L Archer; J Evans; S Edwards; J Colley; R Newbury-Ecob; F O'Callaghan; M Huyton; M O'Regan; J Tolmie; J Sampson; A Clarke; J Osborne
Journal:  J Med Genet       Date:  2006-04-12       Impact factor: 6.318

Review 5.  Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models.

Authors:  Renzo Guerrini; Carla Marini; Massimo Mantegazza
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

6.  Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.

Authors:  Ying Zhao; Xiaoying Zhang; Xinhua Bao; Qingping Zhang; Jingjing Zhang; Guangna Cao; Jie Zhang; Jiarui Li; Liping Wei; Hong Pan; Xiru Wu
Journal:  BMC Med Genet       Date:  2014-02-25       Impact factor: 2.103

7.  Cortical Visual Impairment in CDKL5 Deficiency Disorder.

Authors:  Michela Quintiliani; Daniela Ricci; Maria Petrianni; Simona Leone; Lorenzo Orazi; Filippo Amore; Maria Luigia Gambardella; Ilaria Contaldo; Chiara Veredice; Marco Perulli; Elisa Musto; Eugenio Maria Mercuri; Domenica Immacolata Battaglia
Journal:  Front Neurol       Date:  2022-01-26       Impact factor: 4.003

Review 8.  CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.

Authors:  Nicole J Van Bergen; Sean Massey; Anita Quigley; Ben Rollo; Alexander R Harris; Robert M I Kapsa; John Christodoulou
Journal:  Biochem Soc Trans       Date:  2022-08-31       Impact factor: 4.919

Review 9.  Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies.

Authors:  Kirill Smirnov; Tatiana Stroganova; Sophie Molholm; Olga Sysoeva
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

10.  Genetic basis of pediatric epilepsy syndromes.

Authors:  Dongli Zhang; Xiaoming Liu; Xingqiang Deng
Journal:  Exp Ther Med       Date:  2017-03-27       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.